NeueHealth, Inc.·4

Mar 11, 9:51 PM ET

Craig Jeffery Michael 4

4 · NeueHealth, Inc. · Filed Mar 11, 2025

Insider Transaction Report

Form 4
Period: 2025-03-07
Craig Jeffery Michael
GC & Corporate Secretary
Transactions
  • Sale

    Common Stock

    2025-03-07$7.19/sh1,240$8,91610,167 total
  • Sale

    Common Stock

    2025-03-10$7.06/sh2$1410,746 total
  • Exercise/Conversion

    Common Stock

    2025-03-07+58110,748 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-075810 total
    Common Stock (581 underlying)
Footnotes (5)
  • [F1]These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.10 and $7.25 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.90 and $7.18 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]These restricted stock units vested in three equal annual installments beginning on March 7, 2023.

Documents

1 file
  • 4
    wk-form4_1741744259.xmlPrimary

    FORM 4